A detailed history of Sg Americas Securities, LLC transactions in Insmed Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 21,561 shares of INSM stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,561
Previous 2,477 770.45%
Holding current value
$1.59 Million
Previous $166,000 848.19%
% of portfolio
0.01%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$62.0 - $79.01 $1.18 Million - $1.51 Million
19,084 Added 770.45%
21,561 $1.57 Million
Q2 2024

Jul 12, 2024

SELL
$22.0 - $69.71 $132,682 - $420,421
-6,031 Reduced 70.89%
2,477 $166,000
Q1 2024

May 06, 2024

BUY
$25.72 - $29.94 $120,755 - $140,568
4,695 Added 123.13%
8,508 $231,000
Q4 2023

Jan 12, 2024

SELL
$23.42 - $31.74 $40,165 - $54,434
-1,715 Reduced 31.02%
3,813 $118,000
Q3 2023

Oct 13, 2023

SELL
$19.86 - $26.93 $3.3 Million - $4.48 Million
-166,225 Reduced 96.78%
5,528 $140,000
Q2 2023

Jul 10, 2023

BUY
$16.44 - $21.1 $1.92 Million - $2.46 Million
116,601 Added 211.42%
171,753 $3.62 Million
Q1 2023

Apr 28, 2023

BUY
$16.26 - $21.73 $729,065 - $974,329
44,838 Added 434.73%
55,152 $940,000
Q4 2022

Feb 02, 2023

SELL
$16.98 - $23.15 $115,022 - $156,818
-6,774 Reduced 39.64%
10,314 $206,000
Q3 2022

Oct 31, 2022

SELL
$20.88 - $28.21 $914,752 - $1.24 Million
-43,810 Reduced 71.94%
17,088 $368,000
Q2 2022

Jul 29, 2022

BUY
$17.07 - $25.71 $862,700 - $1.3 Million
50,539 Added 487.88%
60,898 $1.2 Million
Q1 2022

Apr 29, 2022

SELL
$20.42 - $28.13 $696,424 - $959,373
-34,105 Reduced 76.7%
10,359 $243,000
Q4 2021

Feb 07, 2022

SELL
$25.89 - $33.45 $842,641 - $1.09 Million
-32,547 Reduced 42.26%
44,464 $1.21 Million
Q3 2021

Nov 01, 2021

BUY
$22.46 - $29.47 $979,660 - $1.29 Million
43,618 Added 130.62%
77,011 $2.12 Million
Q2 2021

Aug 12, 2021

BUY
$24.17 - $36.01 $586,340 - $873,566
24,259 Added 265.59%
33,393 $950,000
Q1 2021

May 13, 2021

BUY
$32.28 - $44.3 $190,387 - $261,281
5,898 Added 182.26%
9,134 $311,000
Q4 2020

Feb 04, 2021

SELL
$31.45 - $40.54 $930,039 - $1.2 Million
-29,572 Reduced 90.14%
3,236 $108,000
Q3 2020

Nov 09, 2020

BUY
$26.0 - $34.5 $455,416 - $604,302
17,516 Added 114.54%
32,808 $1.05 Million
Q2 2020

Jul 20, 2020

SELL
$14.11 - $29.42 $70,959 - $147,953
-5,029 Reduced 24.75%
15,292 $421,000
Q1 2020

Apr 30, 2020

BUY
$13.63 - $33.98 $218,475 - $544,665
16,029 Added 373.46%
20,321 $326,000
Q4 2019

Jan 28, 2020

BUY
$16.12 - $24.98 $69,187 - $107,214
4,292 New
4,292 $102,000
Q2 2019

Jul 29, 2019

SELL
$23.0 - $32.19 $103,316 - $144,597
-4,492 Closed
0 $0
Q1 2019

Apr 29, 2019

SELL
$13.91 - $31.15 $171,454 - $383,954
-12,326 Reduced 73.29%
4,492 $131,000
Q4 2018

Feb 01, 2019

BUY
$11.6 - $18.7 $195,088 - $314,496
16,818 New
16,818 $221,000
Q3 2018

Nov 06, 2018

SELL
$18.95 - $28.08 $84,896 - $125,798
-4,480 Closed
0 $0
Q2 2018

Aug 07, 2018

SELL
$20.0 - $29.72 $13,160 - $19,555
-658 Reduced 12.81%
4,480 $106,000
Q1 2018

May 03, 2018

BUY
$21.69 - $32.99 $111,443 - $169,502
5,138 New
5,138 $116,000
Q4 2017

Jan 24, 2018

SELL
$26.43 - $31.78 $377,658 - $454,104
-14,289 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$11.61 - $31.21 $165,895 - $445,959
14,289
14,289 $446,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.